Search research articles
Contact Us
Filters
Showing results (331-340 of 358) with videos related to
Page
of 36
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
October 12, 2010
Phase II study of neoadjuvant bevacizumab and radiotherapy for resectable soft tissue sarcomas
Sam S Yoon, Dan G Duda, Daniel L Karl, et al.
JCI Insight
|
June 30, 2026
A tailored in vivo CRISPR screen identifies BAP1 as a potent tumor suppressor of sarcoma
Jianguo Huang, Xingliang Liu, Warren Floyd, et al.
Nature Communications
|
July 11, 2017
Generation and comparison of CRISPR-Cas9 and Cre-mediated genetically engineered mouse models of sarcoma
Jianguo Huang, Mark Chen, Melodi Javid Whitley, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 30, 2019
Neutrophils promote tumor resistance to radiation therapy
Amy J Wisdom, Cierra S Hong, Alexander J Lin, et al.
JAMA Oncology
|
March 30, 2023
Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy: The NRG/RTOG 9514 and 0630 Nonrandomized Clinical Trials
Dian Wang, Jonathan Harris, William G Kraybill, et al.
JCI Insight
|
August 12, 2024
Enhancing radiotherapy response via intratumoral injection of a TLR9 agonist in autochthonous murine sarcomas
Chang Su, Collin L Kent, Matthew Pierpoint, et al.
Biorxiv : the Preprint Server for Biology
|
January 23, 2024
Enhancing radiotherapy response via intratumoral injection of the TLR9 agonist CpG to stimulate CD8 T cells in an autochthonous mouse model of sarcoma
Chang Su, Collin L Kent, Matthew Pierpoint, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
Distinct Sarcoma Microenvironments Predict Benefit from Addition of Pembrolizumab to Preoperative Radiotherapy and Surgery in SU2C-SARC032
Stefano Testa, Jonathon E Himes, Ajay Subramanian, et al.
The Lancet. Oncology
|
May 5, 2018
Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology
Robert G Bristow, Brian Alexander, Michael Baumann, et al.
Molecular Cancer Research : MCR
|
June 21, 2020
The Long Noncoding RNA <i>NEAT1</i> Promotes Sarcoma Metastasis by Regulating RNA Splicing Pathways
Jianguo Huang, Mohit Sachdeva, Eric Xu, et al.
Page
of 36
Search research articles
Search
Showing results (331-340 of 358) with videos related to
Sort By:
Page
of 36
International Journal of Radiation Oncology, Biology, Physics
|
October 12, 2010
Phase II study of neoadjuvant bevacizumab and radiotherapy for resectable soft tissue sarcomas
Sam S Yoon, Dan G Duda, Daniel L Karl, et al.
JCI Insight
|
June 30, 2026
A tailored in vivo CRISPR screen identifies BAP1 as a potent tumor suppressor of sarcoma
Jianguo Huang, Xingliang Liu, Warren Floyd, et al.
Nature Communications
|
July 11, 2017
Generation and comparison of CRISPR-Cas9 and Cre-mediated genetically engineered mouse models of sarcoma
Jianguo Huang, Mark Chen, Melodi Javid Whitley, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 30, 2019
Neutrophils promote tumor resistance to radiation therapy
Amy J Wisdom, Cierra S Hong, Alexander J Lin, et al.
JAMA Oncology
|
March 30, 2023
Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy: The NRG/RTOG 9514 and 0630 Nonrandomized Clinical Trials
Dian Wang, Jonathan Harris, William G Kraybill, et al.
JCI Insight
|
August 12, 2024
Enhancing radiotherapy response via intratumoral injection of a TLR9 agonist in autochthonous murine sarcomas
Chang Su, Collin L Kent, Matthew Pierpoint, et al.
Biorxiv : the Preprint Server for Biology
|
January 23, 2024
Enhancing radiotherapy response via intratumoral injection of the TLR9 agonist CpG to stimulate CD8 T cells in an autochthonous mouse model of sarcoma
Chang Su, Collin L Kent, Matthew Pierpoint, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
Distinct Sarcoma Microenvironments Predict Benefit from Addition of Pembrolizumab to Preoperative Radiotherapy and Surgery in SU2C-SARC032
Stefano Testa, Jonathon E Himes, Ajay Subramanian, et al.
The Lancet. Oncology
|
May 5, 2018
Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology
Robert G Bristow, Brian Alexander, Michael Baumann, et al.
Molecular Cancer Research : MCR
|
June 21, 2020
The Long Noncoding RNA <i>NEAT1</i> Promotes Sarcoma Metastasis by Regulating RNA Splicing Pathways
Jianguo Huang, Mohit Sachdeva, Eric Xu, et al.
Page
of 36